153 related articles for article (PubMed ID: 35704293)
1. Isotretinoin Laboratory Monitoring in Acne Treatment: A Delphi Consensus Study.
Xia E; Han J; Faletsky A; Baldwin H; Beleznay K; Bettoli V; Dréno B; Goh CL; Stein Gold L; Gollnick H; Herane MI; Kang S; Kircik L; Mann J; Nast A; Oon HH; See JA; Tollefson M; Webster G; Zip C; Tan J; Tapper EB; Thiboutot D; Zaenglein A; Barbieri J; Mostaghimi A
JAMA Dermatol; 2022 Aug; 158(8):942-948. PubMed ID: 35704293
[TBL] [Abstract][Full Text] [Related]
2. Laboratory Monitoring During Isotretinoin Therapy for Acne: A Systematic Review and Meta-analysis.
Lee YH; Scharnitz TP; Muscat J; Chen A; Gupta-Elera G; Kirby JS
JAMA Dermatol; 2016 Jan; 152(1):35-44. PubMed ID: 26630323
[TBL] [Abstract][Full Text] [Related]
3. The clinical utility of laboratory monitoring during isotretinoin therapy for acne and changes to monitoring practices over time.
Barbieri JS; Shin DB; Wang S; Margolis DJ; Takeshita J
J Am Acad Dermatol; 2020 Jan; 82(1):72-79. PubMed ID: 31228528
[TBL] [Abstract][Full Text] [Related]
4. [Second joint position paper: Use of isotretinoin in severe acne].
Gómez-Flores M; Poletti-Vázquez DE; García-Hidalgo L; Fierro-Arias L; Herz-Ruelas M; Garza-Gómez J; Rosas-Ortiz JF
Rev Med Inst Mex Seguro Soc; 2019 Jan; 56(5):441-446. PubMed ID: 30777411
[TBL] [Abstract][Full Text] [Related]
5. Standardized laboratory monitoring with use of isotretinoin in acne.
Hansen TJ; Lucking S; Miller JJ; Kirby JS; Thiboutot DM; Zaenglein AL
J Am Acad Dermatol; 2016 Aug; 75(2):323-8. PubMed ID: 27189824
[TBL] [Abstract][Full Text] [Related]
6. Consensus Statements on the Use of Novel Formulations of Isotretinoin: A Modified Delphi Process.
Kingston P; Kircik L; Bhatia N; Del Rosso J; Desai SR; Harper JC; Gold LS; Hougeir F; Armstrong AW
J Drugs Dermatol; 2024 Jun; 23(6):429-432. PubMed ID: 38834212
[TBL] [Abstract][Full Text] [Related]
7. Results of Laboratory Monitoring in Patients Taking Isotretinoin for Acne.
Al-Haddab M; Alhuqayl A; Alsharif H; Alolyet D; Altaleb R
Cutis; 2021 Jul; 108(1):43-45. PubMed ID: 34397358
[TBL] [Abstract][Full Text] [Related]
8. Minimize the regular laboratory monitoring during the systemic isotretinoin treatment: data of 704 patients with acne vulgaris.
Öktem A; Hayran Y; Arı E; Yalçın B
J Dermatolog Treat; 2019 Dec; 30(8):813-817. PubMed ID: 30836808
[No Abstract] [Full Text] [Related]
9. Isotretinoin Monitoring Trends: A National Survey of Dermatologists.
Hobson JG; Cunningham MJ; Lesiak K; Lester EB; Tegeder AR; Zeeck E; Hugh JM; Lin JH
J Drugs Dermatol; 2017 Jun; 16(6):557-564. PubMed ID: 28686773
[TBL] [Abstract][Full Text] [Related]
10. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin.
Ahmad HM
Dermatol Ther; 2015; 28(3):151-7. PubMed ID: 25754162
[TBL] [Abstract][Full Text] [Related]
11. High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life.
Cyrulnik AA; Viola KV; Gewirtzman AJ; Cohen SR
Int J Dermatol; 2012 Sep; 51(9):1123-30. PubMed ID: 22909370
[TBL] [Abstract][Full Text] [Related]
12. A novel predictive method for risk stratification in acne patients receiving isotretinoin: an analysis of laboratory abnormalities and changes in inflammatory parameters.
Murshidi R; Bani Hamad S; Al Refaei A; Shewaikani N; Shaf'ei M; Alshoubaki SN; Haddad TA; Khasawneh T; Fkheideh T; Abdallat M
J Dermatolog Treat; 2024 Dec; 35(1):2301435. PubMed ID: 38186323
[TBL] [Abstract][Full Text] [Related]
13. Laboratory Abnormalities in Acne Patients Treated With Oral Isotretinoin: A Retrospective Epidemiological Study.
Alajaji A; Alrawaf FA; Alosayli SI; Alqifari HN; Alhabdan BM; Alnasser MA
Cureus; 2021 Oct; 13(10):e19031. PubMed ID: 34853752
[TBL] [Abstract][Full Text] [Related]
14. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.
Blasiak RC; Stamey CR; Burkhart CN; Lugo-Somolinos A; Morrell DS
JAMA Dermatol; 2013 Dec; 149(12):1392-8. PubMed ID: 24173086
[TBL] [Abstract][Full Text] [Related]
15. Acne fulminans and isotretinoin: case report.
Pereira MF; Roncada EM; Oliveira CM; Monteiro R; Abreu MA; Ortigosa LC
An Bras Dermatol; 2011; 86(5):983-5. PubMed ID: 22147039
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Laboratory Follow-up in Acne Patients Treated With Isotretinoin.
Özaslan M; Peker D
Cutis; 2023 Jul; 112(1):38-43. PubMed ID: 37611311
[TBL] [Abstract][Full Text] [Related]
17. Isotretinoin does not prolong QT intervals and QT dispersion in patients with severe acne: a surprising finding for a drug with numerous side effects.
Dursun R; Alpaslan M; Caliskan M; Ciftci O; Kulaksizoglu S; Seckin D; Muderrisoglu H
J Drugs Dermatol; 2011 Jul; 10(7):710-4. PubMed ID: 21720652
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of sequential effect of isotretinoin on the haematological parameters in patients with acne vulgaris.
Gencoglan G; Inanir I; Miskioglu M; Gunduz K
Cutan Ocul Toxicol; 2018 Jun; 37(2):139-142. PubMed ID: 28743196
[TBL] [Abstract][Full Text] [Related]
19. Systemic isotretinoin has an impact on hemoglobin, ferritin, urea, ceruloplasmin, albumin, uric acid levels, and neutrophil to lymphocyte ratio in acne patients.
Hareedy MS; Tawfik KM
J Cosmet Dermatol; 2022 Nov; 21(11):6191-6198. PubMed ID: 35770307
[TBL] [Abstract][Full Text] [Related]
20. Creatine phosphokinase values during isotretinoin treatment for acne.
Kaymak Y
Int J Dermatol; 2008 Apr; 47(4):398-401. PubMed ID: 18377609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
